NME1 reduces RNA transcript levels in highly metastatic cells and mutations in this gene have been identified.
This gene (NME1) was identified because of its reduced mRNA transcript levels in highly metastatic cells. Mutations in this gene have been identified in aggressive neuroblastomas. 
